Key result
Clopidogrel is recommended to reduce arterial thromboembolism risk in high-risk feline HCM identified by echo or NT-proBNP.
In cats with asymptomatic hypertrophic cardiomyopathy, screening with NT-proBNP and echocardiography identifies high-risk individuals who benefit from clopidogrel to prevent arterial thromboembolism.
No takes yet. Share an insight, caveat, or question.
May support biomarker screening for feline HCM when echocardiography is limited; leaves open prospective validation before routine use.
Fuentes et al. (2017) conducted a review in Hypertrophic cardiomyopathy in cats. Clopidogrel was evaluated. Clopidogrel is recommended for high-risk cats with hypertrophic cardiomyopathy, identified via echocardiography or NT-proBNP >100 pmol/L, to reduce the risk of arterial thromboembolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: